VAXGEN INC. (VXGN)- The IPO | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
VAXGEN INC. (VXGN)- The IPO

An SI Board Since May 1999

Posts	SubjectMarks	Bans	Symbol
55	4	0	VXGN

Emcee: glen	Type: Unmoderated

Introduction Market Data Compact

VAXGEN INC.

VaxGen, Inc. is offering 3,100,000 shares of its common stock in an initial public offering. Prior to this offering, there has been no public market for VaxGen's common stock.

VaxGen is developing preventive vaccines for worldwide use against HIV. VaxGen conducting two large-scale Phase III clinical trials, one in North America and one in Thailand.

It is anticipated that the public offering price will be between $13.00 and $15.00 per share. The shares of VaxGen will be quoted, subject to approval, in the Nasdaq National Market under the symbol "VXGN".

(Information from S-1 filed 5/7/99)

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
55	VaxGen Wins 2 Separate AIDS Vaccine Patent Disputes Patents Give Exclusive Use	glen	-	5/25/2000
54	VaxGen Inoculates 5,000 Volunteers,(12 Oct 1999), in U.S. Trial of HIV Vaccine;	glen	-	10/12/1999
53	The firm of Punk Ziegel & Company issued a report on VaxGen dated July 27,	gary r. albrecht	-	10/7/1999
52	All I know is that I asked him a question on this thread back in July, and he s	Razorbak	-	9/28/1999
51	Hello Sam, It is unfortunate for the thread that GPSite has been absent from t	glen	-	9/28/1999
50	My thoughts on the price weakness is that it is mostly due to a lack of buying.	glen	-	9/28/1999
49	Apparently GPSite has "left the building". Too bad, given all the ini	Razorbak	-	9/28/1999
48	Anyone know or have thoughts concerning the rapid decline in price? I know thi	gary r. albrecht	-	9/28/1999
47	GPSite: Are VXGN shares marginable yet? Thanks in advance for your response.	Razorbak	-	7/15/1999
46	Paul Allen also has a representative on VaxGen's Board, which is noted in t	glen	-	7/15/1999
45	Manfred, The proof about Paul Allen can be found at the link below. As far as	Dave Budde	-	7/15/1999
44	>Why did Paul Allen buy 800,000 shares (some on the open market > AFTER	Manfred Sondermann	-	7/15/1999
43	Steven, Your comments are prescient. Many millions of dollars are spent on	GPSite	-	7/14/1999
42	thebody.com	Steven	-	7/14/1999
41	GPSite, do you have any knowledge of what has happened to the 2000 humans from	gary r. albrecht	-	7/14/1999
40	Steven, what are you referring (SP?) to, I am not aware of opponents of VAXGE	gary r. albrecht	-	7/14/1999
39	Opponents of VAXGEN are becoming very vocal. Are they afraid that their gravy	Steven	-	7/14/1999
38	VXGN continues to make newer highs, hitting 22 1/2 today!! Genentech is the pa	glen	-	7/12/1999
37	VaxGen Trading @18 3/8, which is a new high.	glen	-	7/12/1999
36	Manfred, I think you are correct in that Genentech is the holder of the patent	gary r. albrecht	-	7/12/1999
35	>VaxGen will have the technology, the mechanics of production, the >pate	Manfred Sondermann	-	7/12/1999
34	Thanks, it helped me a lot !	Manfred Sondermann	-	7/12/1999
33	gary, It is dangerous to extrapolate data from phase I and II trials, and that	GPSite	-	7/11/1999
32	Once again GPSite thanks for taking the time to explain. I am familiar with	gary r. albrecht	-	7/11/1999
31	gary, Truth is, no one really knows how vaccines work. It's theory + empir	GPSite	-	7/10/1999

Go to reply# or date (mm/dd/yy):